Diabetes Board decisions

The Board has granted service connection for diabetes mellitus type II due to herbicide exposure. The issues of entitlement to service connection for an eye condition and a bilateral foot disorder as secondary to the veteran's service-connected diabetes mellitus are remanded.

The veteran's claims for service connection for diabetes mellitus, peripheral neuropathy of the lower extremities, and peripheral vascular disease were denied as these conditions did not develop due to inservice exposure to herbicides or military service.

The Board finds that the veteran's diabetes, which was related to herbicide exposure during his service in Vietnam, contributed to or accelerated his death. Therefore, service connection for the cause of the veteran's death is granted.

The Board has remanded the case for additional development, including obtaining medical records and scheduling VA examinations to determine the current severity of the veteran's service-connected psychophysiologic cardiac reaction and need for aid and attendance.

The Board has remanded the case for additional development due to incomplete records and further review.

The veteran is granted service connection for type II diabetes mellitus as due to herbicide exposure based on his receipt of the Vietnam Service Medal.

The Board has denied service connection for right and left knee disabilities and diabetes mellitus, finding that these conditions are not causally related to or aggravated by the veteran's service-connected coronary artery disease, congestive heart failure with renal insufficiency, and AICD placement.

The Board has determined that the veteran's diabetes mellitus, type II, may be presumed to have been incurred in active service due to exposure to herbicide agents during his Vietnam-era service. As a result, the appeal is granted.

The Board denied the veteran's increased rating claims for superficial squamous cell carcinoma of the scalp and basal cell carcinoma on the face, finding that his service-connected condition did not meet the criteria for a higher evaluation under either the old or new rating criteria.

The Board has determined that the veteran's current diagnosis of diabetes mellitus is related to his active duty service, and thus grants service connection for this condition.

The veteran's diabetes mellitus is presumed to have been incurred during active service due to herbicide exposure. The right ring and little fingers disabilities are rated at the maximum allowable under the applicable rating criteria.

The Board has remanded the case for additional development due to failure of the appellant to report for scheduled VA examinations. The claim will be evaluated based on the evidence of record.

The Board found that the cause of death was not due to any service-connected disability and denied DIC benefits under 38 U.S.C.A. § 1318.

The VA denied the veteran's claim for an initial disability evaluation in excess of 20 percent for diabetes mellitus, type 2. The current rating is 20 percent.

The veteran's diabetes mellitus is rated at 20 percent. The RO denied his claims for higher ratings for peripheral neuropathy of the right and left lower extremities, finding that he did not meet the criteria for a higher rating based on his symptoms.

The Board found no evidence of fault or negligence on the part of VA in providing medical care for the veteran's right fibular fracture, and thus denied compensation under 38 U.S.C.A. § 1151.

The Board denied the claim for service connection for the cause of the veteran's death, finding no evidence that his conditions were caused or aggravated by his military service.

The veteran's diabetes mellitus is currently rated at 20 percent, and his peripheral neuropathy of the right and left lower extremities are each rated at 10 percent. The Board finds that separate compensable ratings for the peripheral neuropathy cannot be granted.

The Board denied service connection for PTSD and hepatitis C, but granted service connection for diabetes mellitus with a 20 percent disability rating effective May 8, 2002.

The veteran's diabetes mellitus with nonproliferative diabetic retinopathy is being remanded for additional examinations and evidence to determine the appropriate rating.